What changed
$AMAT — AVOID 📊 | 6 MONTHS THESIS
🧭 Conviction: HIGH
🎯 FQ2 FY2026 (ends Apr) | reported May 14 | Rev $7.9B | EPS $2.86 vs $2.69 🟢 | Margin 31.9%
💡 The market prices AMAT as if its current earnings peak will persist and grow uninterrupted forever, with an implied FCF growth of just 6.4%. Consensus extrapolates recent beats, but cyclicality in semiconductor capex and extreme valuation compression risk are ignored.
📉 Reward/risk: 2.6:1
🏢 Business Quality: 8/10
📊 Valuation: rich — trailing P/E 54.8x vs. historical median 14.0x and peer band 7.4x–18.7x; reverse DCF implies 6.4% FCF growth perpetually; base-case fair value...
🔮 Catalyst: next quarterly earnings release or industry capex guidance
💰 Entry: $626.84, stop $752.9, target $304.74
⚖️ Avoid: The stock is dangerously overvalued relative to any historical peer or cycle analogue, offering negative reward/risk on a 6-month horizon.